deltatrials
Completed NCT00118664

Patient Plasma Response and Outcome in Septic Shock With Thrombocytopenia Associated Multiple Organ Failure in Children

Sponsor: Children's Healthcare of Atlanta

Updated 7 times since 2017 Last updated: Jun 13, 2016 Started: May 31, 2005 Primary completion: Feb 29, 2012 Completion: Feb 29, 2012

Listed as NCT00118664, this observational or N/A phase trial focuses on Multiple Organ Failure and Septic Shock and remains completed. Sponsored by Children's Healthcare of Atlanta, it has been updated 7 times since 2005, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Change History

7 versions recorded
  1. Sep 2025 — Present [monthly]

    Completed

  2. Sep 2024 — Sep 2025 [monthly]

    Completed

  3. Jul 2024 — Sep 2024 [monthly]

    Completed

  4. Jan 2021 — Jul 2024 [monthly]

    Completed

  5. Jun 2018 — Jan 2021 [monthly]

    Completed

Show 2 earlier versions
  1. Apr 2018 — Jun 2018 [monthly]

    Completed

    Phase: NANone

  2. Jan 2017 — Apr 2018 [monthly]

    Completed NA

    First recorded

May 2005

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Children's Healthcare of Atlanta
Data source: Children's Healthcare of Atlanta

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Ann Arbor, United States, Atlanta, United States, Cincinnati, United States, Columbus, United States, Fort Worth, United States, Houston, United States, Iowa City, United States, Minneapolis, United States, Nashville, United States, Pittsburgh, United States and 2 more location s